QUEST DIAGNOSTICS INC
DGX · XNYSCIK 1022079fmd_1QR409R9XEW1YSV5C8D6QC7A72Services · Services-Medical LaboratoriesTemplate: Standard
Coverage: Jan 01, 2007 to Sep 30, 2026, 75 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 7,214 | 7,402 | 7,531 | 7,726 | 9,437 | 10,788 | 9,883 | 9,252 | 9,872 | 11,035 |
| Total interest income | 1 | 2 | 2 | 5 | 3 | 1 | 10 | 11 | 25 | 13 |
| Cost of revenue | 4,616 | 4,719 | 4,926 | 5,037 | 5,804 | 6,579 | 6,450 | 6,199 | 6,628 | 7,370 |
| Net interest income | (143) | (151) | (167) | (175) | (163) | (151) | (138) | (152) | (201) | (264) |
| Gross profit | 2,899 | 2,683 | 2,605 | 2,689 | 3,633 | 4,209 | 3,433 | 3,053 | 3,244 | 3,665 |
| Realized investment gains (losses) | – | – | – | – | – | – | – | – | – | – |
| Selling, general and administrative | 1,380 | 1,443 | 1,424 | 1,457 | 1,550 | 1,727 | 1,874 | 1,642 | 1,770 | 1,967 |
| Operating income | 1,277 | 1,165 | 1,101 | 1,231 | 1,971 | 2,381 | 1,428 | 1,262 | 1,346 | 1,556 |
| Interest expense | 144 | 153 | 169 | 180 | 166 | 152 | 148 | 163 | 226 | 277 |
| Interest and investment income | – | – | – | – | – | – | – | – | – | – |
| Other non-operating income (expense) | (191) | (135) | (175) | (155) | (87) | 218 | (193) | (132) | (171) | (238) |
| Income before taxes | 1,086 | 1,030 | 926 | 1,076 | 1,884 | 2,599 | 1,235 | 1,130 | 1,175 | 1,318 |
| Income tax expense | 429 | 241 | 182 | 247 | 460 | 597 | 264 | 248 | 273 | 314 |
| Net income from continuing operations | 696 | 824 | 788 | 886 | 1,499 | 2,080 | 971 | 882 | 902 | 1,004 |
| Net income | 645 | 772 | 736 | 858 | 1,431 | 1,995 | 946 | 854 | 871 | 992 |
| Net income to common shareholders | 642 | 769 | 733 | – | – | – | – | – | – | – |